What specific financial guidance did CVS Health raise for 2026, and what key factor drove this upward revision?

CVS Health raised its 2026 adjusted profit per share forecast to a range of $7.30 to $7.50, up from the prior range of $7.00 to $7.20; this revision reflects lower spending on medical costs in its health insurance business, particularly within Aetna, where the medical loss ratio improved to 84.6%—well below analysts’ estimate of 87.58% and down from 87.3% in the prior year.

How did CVS Health’s pharmacy business perform in the first quarter of 2025 despite growth in prescriptions and customers?

Although CVS Health’s pharmacy business grew 5% in 2025 and gained 9 million customers after finalizing its Rite Aid acquisition—enabling it to fill more prescriptions and dispense more expensive drugs—its operating income for that unit fell 8.8% year-over-year due to higher operating costs driven by regulatory changes affecting drug pricing, a smaller share of cold and flu illnesses being treated, and weather disruptions—including store closures due to snow—that slowed operations.

CVS Health raises 2026 forecast after improving medical cost controls

May 6, 2026

CVS Health raised its 2026 profit forecast citing improved medical cost controls and a more profitable drug mix at Caremark. Shares rose 4% as the company beat quarterly earnings estimates despite regulatory challenges in its pharmacy unit.

reuters

2026-05-06

CVS Health raises 2026 forecast after improving medical cost controls

2026-07-14

CVS Settles with FTC to Include TrumpRx Purchases in Insurance Deductibles

2026-08-05

CVS Raises Annual Profit Forecast on Improved Drug Revenues

CVS Health raises 2026 forecast after improving medical cost controls

FAQ